Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

Summary: Recurrent copy-number alterations, mutations, and transcript fusions of the genes encoding CDKs/cyclins are characterized in >10,000 tumors. Genomic alterations of CDKs/cyclins are dominantly driven by copy number aberrations. In contrast to cell-cycle-related CDKs/cyclins, which are glo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Weiwei Shan, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yueying Wang, Nicki Loo, Lingling Fan, Zhaoqing Tang, Tianli Zhang, Mu Xu, Yutian Pan, Jiaqi Lu, Meixiao Long, Janos L. Tanyi, Kathleen T. Montone, Yi Fan, Xiaowen Hu, Youyou Zhang, Lin Zhang
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020-07-01
Edice:Cell Reports
Témata:
genomic alteration
cyclin-dependent kinase
cancer
CDK7 inhibitor
PARP inhibitor
combination therapy
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2211124720308652
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
Načítá se...

Podobné jednotky